Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

Pediatrics

Volumn 108, Issue 5, 2001, Pages

  Michelson, D ^a   Faries, D ^a   Wernicke, J ^a   Kelsey, D ^a   Kendrick, K ^a   Sallee, F R ^a   Spencer, T ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; NEW DRUG; PROPYLAMINE;

ADOLESCENT; AGE; ALGORITHM; ANALYSIS OF VARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; AGE FACTORS; ALGORITHMS; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, INVESTIGATIONAL; FEMALE; HUMANS; MALE; PROPYLAMINES;

MLCS; MLOWN;

EID: 0035511622     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.108.5.e83     Document Type: Article

References (0)